Guida, F., Tan, V. Y., Corbin, L. J., Smith-Byrne, K., Alcala, K., Langenberg, C., Stewart, I. D., Butterworth, A. S., Surendran, P., Achaintre, D., Adamski, J., Amiano Exezarreta, P., Bergmann, M. M., Bull, C. J.
, Dahm, C. C., Gicquiau, A., Giles, G. G., Gunter, M. J., Haller, T. ... Johansson, M. (2021).
The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium.
PLOS Medicine,
18(9), Article e1003786.
https://doi.org/10.1371/journal.pmed.1003786
Wiggers, H., Køber, L., Gislason, G., Schou, M., Poulsen, M. K., Vraa, S., Nielsen, O. W., Bruun, N. E.
, Nørrelund, H., Hollingdal, M., Barasa, A.
, Bøttcher, M., Dodt, K., Hansen, V. B., Nielsen, G.
, Knudsen, A. S., Lomholdt, J., Mikkelsen, K. V., Jonczy, B. ... Gustafsson, F. (2021).
The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT).
American Heart Journal,
231, 137-146.
https://doi.org/10.1016/j.ahj.2020.09.020,
https://doi.org/10.1016/j.ahj.2020.09.020